Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

New research has highlighted the profound link between dietary choices and brain health. Published in Nature, the research showed that a healthy, balanced diet was linked to superior brain health, ...

Netflix’s The Hunting Wives is a salacious and sultry murder mystery — but how does the TV adaptation compare to the original book? “There are a lot of similarities to the book, and then not,” Lowes ...

In a recent social media post, Peter Ray, senior director of medicinal chemistry at Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), drew attention to a new article in WIRED from Veronique Greenwood ...

While dementia and Alzheimer’s disease are terms that are often used interchangeably, they don’t mean the same thing. Understanding the difference isn’t just helpful for clarity, it’s essential for ...

Boltz-2 is the first biomolecular co-folding model to combine structure and binding affinity prediction, approaching the accuracy of physics-based free energy perturbation (FEP) calculations but at ...

SPOILER ALERT: This post contains spoilers for both seasons of The Last Of Us. HBO‘s television adaptation of the Sony Playstation game The Last Of Us took several departures from its source material ...

If you thought movies based on books that change things made people upset, wait until you see what happens when a beloved animated movie gets the live-action adaptation treatment. Older movies can ...

Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) fell this week. The stock lost 24% as of market close on Friday. The move comes as the S&P 500 and Nasdaq Composite both slipped slightly. Recursion ...